These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20455854)

  • 1. TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy.
    Yang L
    Curr Mol Med; 2010 Jun; 10(4):374-80. PubMed ID: 20455854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFbeta and cancer metastasis: an inflammation link.
    Yang L
    Cancer Metastasis Rev; 2010 Jun; 29(2):263-71. PubMed ID: 20437081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?
    Yang L; Moses HL
    Cancer Res; 2008 Nov; 68(22):9107-11. PubMed ID: 19010878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.
    Yang L; Pang Y; Moses HL
    Trends Immunol; 2010 Jun; 31(6):220-7. PubMed ID: 20538542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive and promoting function of transforming growth factor beta.
    Sun L
    Front Biosci; 2004 May; 9():1925-35. PubMed ID: 14977598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting TGFbeta signaling for cancer therapy.
    Iyer S; Wang ZG; Akhtari M; Zhao W; Seth P
    Cancer Biol Ther; 2005 Mar; 4(3):261-6. PubMed ID: 15846079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TGFbeta signaling in cancer therapy.
    Arteaga CL
    Curr Opin Genet Dev; 2006 Feb; 16(1):30-7. PubMed ID: 16377175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.
    Tauriello DVF; Palomo-Ponce S; Stork D; Berenguer-Llergo A; Badia-Ramentol J; Iglesias M; Sevillano M; Ibiza S; Cañellas A; Hernando-Momblona X; Byrom D; Matarin JA; Calon A; Rivas EI; Nebreda AR; Riera A; Attolini CS; Batlle E
    Nature; 2018 Feb; 554(7693):538-543. PubMed ID: 29443964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta signaling and its targeted therapy in gastrointestinal cancers.
    Gotovac JR; Fujihara KM; Phillips WA; Clemons NJ
    Discov Med; 2018 Sep; 26(142):103-112. PubMed ID: 30399328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of TGFbeta in metastasis.
    Padua D; Massagué J
    Cell Res; 2009 Jan; 19(1):89-102. PubMed ID: 19050696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models
    Yang Y; Yang HH; Tang B; Wu AML; Flanders KC; Moshkovich N; Weinberg DS; Welsh MA; Weng J; Ochoa HJ; Hu TY; Herrmann MA; Chen J; Edmondson EF; Simpson RM; Liu F; Liu H; Lee MP; Wakefield LM
    Clin Cancer Res; 2020 Feb; 26(3):643-656. PubMed ID: 31582516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
    Pardali K; Moustakas A
    Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ: A player on multiple fronts in the tumor microenvironment.
    Caja F; Vannucci L
    J Immunotoxicol; 2015; 12(3):300-7. PubMed ID: 25140864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the TGFβ pathway for cancer therapy.
    Neuzillet C; Tijeras-Raballand A; Cohen R; Cros J; Faivre S; Raymond E; de Gramont A
    Pharmacol Ther; 2015 Mar; 147():22-31. PubMed ID: 25444759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF beta inhibition for cancer therapy.
    Saunier EF; Akhurst RJ
    Curr Cancer Drug Targets; 2006 Nov; 6(7):565-78. PubMed ID: 17100564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.
    Ng S; Deng J; Chinnadurai R; Yuan S; Pennati A; Galipeau J
    Cancer Res; 2016 Oct; 76(19):5683-5695. PubMed ID: 27488533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
    Tan AR; Alexe G; Reiss M
    Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis.
    Principe DR; DeCant B; Mascariñas E; Wayne EA; Diaz AM; Akagi N; Hwang R; Pasche B; Dawson DW; Fang D; Bentrem DJ; Munshi HG; Jung B; Grippo PJ
    Cancer Res; 2016 May; 76(9):2525-39. PubMed ID: 26980767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.
    Oft M; Heider KH; Beug H
    Curr Biol; 1998 Nov; 8(23):1243-52. PubMed ID: 9822576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polarization of immune cells in the tumour environment by TGFbeta.
    Flavell RA; Sanjabi S; Wrzesinski SH; Licona-Limón P
    Nat Rev Immunol; 2010 Aug; 10(8):554-67. PubMed ID: 20616810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.